SALT LAKE CITY - SINTX Technologies, Inc. (NASDAQ: SINT), a manufacturer of advanced ceramics, announced today its intention to conduct a public offering of its common stock. The company aims to raise capital primarily for working capital and general corporate purposes. The timing and completion of the offering are dependent on market conditions, and there is no certainty regarding the completion of the offering or the terms involved.
Maxim Group LLC has been appointed as the sole placement agent for the offering on a reasonable best efforts basis. The offering will be conducted in accordance with an effective shelf registration statement, including a preliminary prospectus supplement and an accompanying prospectus filed with the U.S. Securities and Exchange Commission (SEC), available on the SEC's website.
SINTX Technologies specializes in the development and commercialization of silicon nitride for medical and technical applications and has been a part of the medical implant industry since 2008. Over the last two years, SINTX has expanded into new markets through strategic acquisitions and partnerships. It operates manufacturing facilities in Utah and Maryland.
The company's announcement includes forward-looking statements subject to risks and uncertainties, such as the timing and conditions of the offering, market acceptance of its products, and competition from other products. The company's ability to complete the offering is not guaranteed.
Investors and interested parties can obtain the preliminary prospectus supplement and accompanying prospectus by contacting Maxim Group LLC. The securities may not be sold in any jurisdiction where the offer, solicitation, or sale would be unlawful without registration or qualification under the securities laws of that jurisdiction.
This news is based on a press release statement and provides an overview of SINTX Technologies' planned public offering and its business operations.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.